Business Context and Reporting Period
This Form 8-K is a current report filed by Catalyst Biosciences, Inc. (not Gyre Therapeutics, Inc., as noted in the metadata) on September 4, 2015. The report covers events occurring on August 31, 2015, specifically regarding a change in the company's principal independent registered public accounting firm.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly procedural regarding the appointment of an auditor.
Material Changes
- Accountant Change: The Audit Committee approved the engagement of EisnerAmper LLP as the principal independent registered public accounting firm, effective September 1, 2015.
- Dismissal of Prior Auditor: Ernst & Young LLP was dismissed as the principal independent registered public accounting firm effective September 1, 2015.
- Audit History: The reports issued by Ernst & Young for the fiscal years ended December 31, 2013, and December 31, 2014, did not contain adverse opinions, disclaimers, or qualifications regarding uncertainty, audit scope, or accounting principles.
Guidance, Risks, and Contingencies
The filing states there were no "disagreements" or "reportable events" between the company and Ernst & Young during the fiscal years 2013 and 2014, or the interim period through September 1, 2015. Additionally, the company did not consult with EisnerAmper regarding accounting principles or audit opinions prior to the engagement. No financial guidance or outlook is provided in this document.
Investor Verification Checklist
- Verify the effective date of the new auditor (EisnerAmper LLP) is September 1, 2015.
- Confirm that the prior auditor (Ernst & Young LLP) issued a letter agreeing with the company's disclosures (Exhibit 16.1).
- Review the company's most recent 10-K or 10-Q filings for actual financial performance metrics, as this 8-K contains none.
- Note the discrepancy between the metadata company name (Gyre Therapeutics) and the filing registrant (Catalyst Biosciences).